{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:09:40Z","timestamp":1777936180745,"version":"3.51.4"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.2169\/internalmedicine.6068-25","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:07:58Z","timestamp":1759961278000},"page":"1307-1312","source":"Crossref","is-referenced-by-count":0,"title":["Progressive Supranuclear Palsy with Predominant Speech\/Language Disorder"],"prefix":"10.2169","volume":"65","author":[{"given":"Shinichiro","family":"Maeshima","sequence":"first","affiliation":[{"name":"National Center for Geriatrics and Gerontology, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Sakurai","sequence":"additional","affiliation":[{"name":"National Center for Geriatrics and Gerontology, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Osawa","sequence":"additional","affiliation":[{"name":"National Center for Geriatrics and Gerontology, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Arai","sequence":"additional","affiliation":[{"name":"National Center for Geriatrics and Gerontology, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Takeda","sequence":"additional","affiliation":[{"name":"National Center for Geriatrics and Gerontology, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Golbe LI. Progressive supranuclear palsy. Semin Neurol 34: 151-159, 2014.","DOI":"10.1055\/s-0034-1381736"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128: 1247-1258, 2005.","DOI":"10.1093\/brain\/awh488"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 38: 1031-1034, 1988.","DOI":"10.1212\/WNL.38.7.1031"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJ. Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 60: 910-916, 2003.","DOI":"10.1212\/01.WNL.0000052991.70149.68"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Snowden JS, Kobylecki C, Jones M, Thompson JC, Richardson AM, Mann DAM. Association between semantic dementia and progressive supranuclear palsy. J Neurol Neurosurg Psychiat 90: 115-117, 2019.","DOI":"10.1136\/jnnp-2017-317839"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Esmonde T, Giles E, Xuereb J, Hodges J. Progressive supranuclear palsy presenting with dynamic aphasia. J Neurol Neurosurg Psychiatry 60: 403-410, 1996.","DOI":"10.1136\/jnnp.60.4.403"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. H\u00f6glinger GU, Respondek G, Stamelou M, et al.; Movement Disorder Society-endorsed PSP Study Group. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32: 853-864, 2017.","DOI":"10.1002\/mds.26973"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hokelekli FO, Duffy JR, Clark HM, et al. Autopsy Validation of Progressive Supranuclear Palsy-Predominant Speech\/Language Disorder Criteria. Mov Disord 37: 213-218, 2022.","DOI":"10.1002\/mds.28822"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, H\u00f6glinger GU. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16: 552-563, 2017.","DOI":"10.1016\/S1474-4422(17)30157-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kertesz A, Finger E, Munoz DG. Progress in primary progressive aphasia: a review. Cogn Behav Neurol 37: 3-12, 2024.","DOI":"10.1097\/WNN.0000000000000365"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10: 333-359, 1964.","DOI":"10.1001\/archneur.1964.00460160003001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 23: 394-400, 2010.","DOI":"10.1097\/WCO.0b013e32833be924"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Cotelli M, Borroni B, Manenti R, et al. Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration. Neuropsychology 20: 558-565, 2006.","DOI":"10.1037\/0894-4105.20.5.558"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sakurai K, Kaneda D, Morimoto S, et al. Asymmetric cerebral peduncle atrophy: a simple diagnostic clue for distinguishing frontotemporal lobar degeneration from Alzheimer's disease. J Alzheimers Dis 95: 1657-1665, 2023.","DOI":"10.3233\/JAD-230441"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiat 60: 615-620, 1996.","DOI":"10.1136\/jnnp.60.6.615"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Sakurai K, Tokumaru AM, Shimoji K, et al. Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. Neuroradiology 59: 431-443, 2017.","DOI":"10.1007\/s00234-017-1812-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sakurai K, Kaneda D, Morimoto S, et al. Asymmetric cerebral peduncle atrophy: a simple diagnostic clue for distinguishing frontotemporal lobar degeneration from Alzheimer's disease. J Alzheimers Dis 95: 1657-1665, 2023.","DOI":"10.3233\/JAD-230441"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Berthier ML, Hoet F, Beltr\u00e1n-Corbellini \u00c1, Santana-Moreno D, Edelkraut L, D\u00e1vila G. Case report: barely able to speak, can't stop echoing: echolalic dynamic aphasia in progressive supranuclear palsy. Front Aging Neurosci 13: 635896, 2021.","DOI":"10.3389\/fnagi.2021.635896"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kluin KJ, Foster NL, Berent S, Gilman S. Perceptual analysis of speech disorders in progressive supranuclear palsy. Neurology 43: 563-566, 1993.","DOI":"10.1212\/WNL.43.3_Part_1.563"},{"key":"20","unstructured":"20. Bergeron D, Gorno-Tempini ML, Rabinovici GD, et al. Prevalence of amyloid-\u03b2 pathology in distinct variants of primary progressive aphasia. Ann Neurol 84: 729-740, 2018."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and multiple system atrophy (MSA). Neurocase 11: 268-273, 2005.","DOI":"10.1080\/13554790590962997"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Robinson G, Shallice T, Cipolotti L. Dynamic aphasia in progressive supranuclear palsy: a deficit in generating a fluent sequence of novel thought. Neuropsychologia 44: 1344-1360, 2006.","DOI":"10.1016\/j.neuropsychologia.2006.01.002"},{"key":"23","unstructured":"23. Aiba I, Hayashi Y, Shimohata T, et al.; J-VAC study group. Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome. Brain Commun 5: fcad296, 2023."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sakurai K, Tokumaru AM, Yoshida M, et al.; J-VAC study group. Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study. Neuroradiology 66: 1917-1929, 2024.","DOI":"10.1007\/s00234-024-03432-w"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_6068-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:22:03Z","timestamp":1777692123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_6068-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6068-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"6068-25"}}